Thursday, January 12, 2023 7:40:20 PM
PM,
The FlaskWorks unit is clearly far superior to using a single cleanroom to make a single batch. With personalize products it's impossible to put them into something making more than one batch of the product at a time. The FlaskWorks unit is actually quite an elegant solution to the problem.
Can improvements be made to it, certainly. Perhaps in time they'll find ways of accelerating the process, one day instead of one week, than one hour instead of one day. Who knows what the future may hold, but for now it's dramatically better than manually making the vaccine in a small, isolated clean room.
The first ink jet I saw was much bigger, far slower, and nowhere near as clear printing, and far more expensive than todays ink jets, and they were hard wired to a single computer. Today's printers also scan, fax, print two sided, far higher quality, much lower cost, much faster printing, wirelessly attach to all sorts of things, yet they're still ink jets. In time the same will probably be true of the FlaskWorks units, no doubt they can be packaged more neatly, perhaps they'll be housed not to show all the tubing and connectors, but it will all be under the hood. Let's get the first one approved, than we can work on the Mach 2 version.
Who knows, perhaps in the future on surgically removing the tumor it will be placed into a device right in the operating room where it's added to the other needed components and by the time the operations over they're injecting DCVax-L into the IV. Maybe even the surgery won't be needed, they'll suck the lysate right out of the tumor with a probe and surgery won't be required at all. No telling where the future may go, but for now, the FlaskWorks unit is a major step up, if DNDN had something like it ages ago they'd probably be a biotech giant, and perhaps we wouldn't exist, as they'd have created DCVax-L long ago.
Gary
The FlaskWorks unit is clearly far superior to using a single cleanroom to make a single batch. With personalize products it's impossible to put them into something making more than one batch of the product at a time. The FlaskWorks unit is actually quite an elegant solution to the problem.
Can improvements be made to it, certainly. Perhaps in time they'll find ways of accelerating the process, one day instead of one week, than one hour instead of one day. Who knows what the future may hold, but for now it's dramatically better than manually making the vaccine in a small, isolated clean room.
The first ink jet I saw was much bigger, far slower, and nowhere near as clear printing, and far more expensive than todays ink jets, and they were hard wired to a single computer. Today's printers also scan, fax, print two sided, far higher quality, much lower cost, much faster printing, wirelessly attach to all sorts of things, yet they're still ink jets. In time the same will probably be true of the FlaskWorks units, no doubt they can be packaged more neatly, perhaps they'll be housed not to show all the tubing and connectors, but it will all be under the hood. Let's get the first one approved, than we can work on the Mach 2 version.
Who knows, perhaps in the future on surgically removing the tumor it will be placed into a device right in the operating room where it's added to the other needed components and by the time the operations over they're injecting DCVax-L into the IV. Maybe even the surgery won't be needed, they'll suck the lysate right out of the tumor with a probe and surgery won't be required at all. No telling where the future may go, but for now, the FlaskWorks unit is a major step up, if DNDN had something like it ages ago they'd probably be a biotech giant, and perhaps we wouldn't exist, as they'd have created DCVax-L long ago.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
